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Abstract
A 64-year-old British Caucasian man presented with red skin wheals and breathlessness and then
developed a progressive neurological syndrome. Investigation revealed hereditary haemachromatosis,
porphyria, and a myelodysplastic syndrome. No unifying diagnosis was made, and his neurological
symptoms remained unexplained, until further studies revealed an underlying copper deficiency.
Case presentation
A 64-year-old British Caucasian man became unwell with
a generalised rash, breathlessness and fatigue in late 1999,
the day after returning from a golfing holiday in Palm
Springs. He was noted to be suntanned, had an ecze-
matous rash around the neck, and had generalised raised
erythematous wheals. He had lost weight in recent weeks.
He had only ever drunk alcohol in moderation and had
smoked only briefly at school. He had no history of bowel
disease or any previous surgery. There was no family
history of neurological disease.
Examination at this stage was otherwise unremarkable.
Skin biopsy showed inflammatory changes only and he
was treated symptomatically. Other investigations found
raised inflammatory indices, an abnormal blood film with
mild macrocytic anaemia and neutropenia, and increased
liver transaminases. B12 and folate were normal. Bone
marrow biopsy confirmed that both erythroid and
myeloid cells lines were affected, but there were no
chromosome or T cell abnormalities. A myelodysplastic
syndrome was thought to be likely.
On liver ultrasound scan there was increased echogenicity
and MRI suggested iron deposition. He had high serum
ferritin and transferrin saturation, and a liver biopsy
showed iron deposition and fibrosis. Despite a lack of
family history, genetic testing gave a diagnosis of here-
ditary haemochromatosis (C282Y homozygote).
Whilst he was undergoing these investigations he devel-
oped neurological symptoms: aching below the knees and
then gait unsteadiness. There was also numbness of the
fingers, but this did not progress.
On neurological examination, there was a fine tremor
without pseudoathetosis and a severely ataxic gait with a
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(page number not for citation purposes)positive Romberg test. Cranial nerves were normal. There
was mild wasting of the quadriceps and anterior calf
muscles, but no wasting of the upper limbs. Tone and
power were normal. Reflexes were present with crossed
adductors. Pin-prick sensation was reduced to mid-thigh,
light touch reduced to below the knees, proprioception
was reduced to the hips, and vibration reduced to the
costal margins. Nerve conduction studies showed a mild
to moderate generalised sensorimotor axonal polyneuro-
pathy, which was felt to be insufficient to fully explain his
sensory ataxia. He had normal imaging of brain and spinal
cord other than moderate cervical spondylosis without
cord signal change. There was no lumbar root enhance-
ment. Somatosensory evoked potentials were absent from
the lower limbs. Cerebrospinal fluid was normal other
than slightly raised protein at 0.7 g/dl.
Further investigation revealed a mildly raised homo-
cysteine though normal urinary methylmalonic acid.
Urinary porphyrins were raised and detailed urinary and
faecal porphyrin studies indicated a defect at the level of
uroporphyrinogen decarboxylase, consistent with a diag-
nosis of porphyria cutanea tarda.
Paraneoplastic disease was considered, but PET scan,
whole body CT, upper and lower GI endoscopy were all
normal. He was treated with B12 and has had this
regularly since and also commenced regular venesection
which has successfully normalised iron stores.
At this stage, this man with a profound sensory ataxia had
accrued three new diagnoses of myelodysplasia, hereditary
haemachromatosis and porphyria cutanea tarda; none of
which explained his neurological phenotype. These could
be linked only in that iron overload can precipitate
porphyria cutanea tarda.
His neurological problems progressed to numbness below
the knees and he developed further unsteadiness, requir-
ing a stick to walk after one month and two sticks after two
months. A year later he had developed extensor plantars,
a very severe allodynia and painful paraesthesiae in the
legs. He became wheelchair dependent by two years and
continued to lose a total of 3 stones in weight.
At this stage, in 2001, he was re-investigated and was found
to have a very low copper level at 0.37 μmol/L (reference
range12-20),evenafterreinitiatingvenesection,andaraised
zinc level at 34.4 μmol/L (reference range 10-18). Caerulo-
plasmin was low at 0.02 g/l (reference range 0.2-0.4 g/L).
Copper excretion studies showed normal urinary copper
excretion of < 0.1 μmol/day (reference range <1 μmol/
day). Copper excretion after a penicillamine challenge
increased to 1.20 μmol/day (normal subjects <25 μmol/
day, Wilson Disease > 25 μmol/day), and there was a
cyclic and inverse variation in serum copper and zinc
concentrations with the copper level seeming to fall
around the times of therapeutic phlebotomy.
He was given five days treatment with intravenous
copper sulphate (2 mg/day), then oral copper sulphate
(2 mg/day), and the neuropathic pains significantly
abated and he was able to stand at the sink and in the
shower. He continued oral copper sulphate for the next
18 months and remained stable.
Discussion
Chronic sensory ataxia can occur secondary to inherited
conditions (e.g. spinocerebellar ataxias, Friedrichs ataxia),
infections (e.g. tabes dorsalis, HIV), vitamin deficiency
(e.g. B12, folate, vitamin E), toxins (e.g. pyridoxine),
paraneoplasia and immune syndromes (e.g. Sjogrens
syndrome and inflammatory neuropathies). The under-
lying pathology can be in the sensory nerve, dorsal root
ganglion, dorsal root, dorsal root entry zone or dorsal
column of the spinal cord.
The first report of a copper deficiency myeloneuropathy in
humans was published in 2001, shortly before our patient
was investigated for the second time, in a female with
previous partial gastrectomy [1]. A similar ataxic myelo-
pathy had been described as Swayback disease in various
animals for many years [2]. In Swayback disease, Wallerian
degeneration occurs, characterised by demyelination and
microcavitation especially in the white matter of the
cervical cord. Recently, imaging studies in some human
cases of copper deficiency have shown T2 hyperintensity in
the dorsal cervical and thoracic cord [3].
Since then, a handful of case reports have been published,
mostly in patients following gastrectomy [1,4-6], but even
in these patients it is rare, and additional insults such as
small bowel bacterial overgrowth have been postulated
[7], presumably to exacerbate malabsorption. Cases can be
associated with haematological problems and may or may
not show MRI hyperintensities in brain and cord.
Zinc toxicity is another cause of copper deficiency [8]: Both
copper and zinc are absorbed in the stomach and proximal
duodenum. High zinc levels cause up-regulation of
enterocyte metallothionein, a binding protein for both
copper and zinc. Copper binds to metallothionein more
avidly than zinc, remains in the enterocyte and is sloughed
into the small bowel lumen, and thus not absorbed. It is
also known that Clioquinol, a Cu/Zn chelating antibiotic
used in Japan in the 1970’s, caused subacute myelo-
optico-neuropathy [9].
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There are complex relationships between the trace
elements that were abnormal in our patient and theore-
tically the pathophysiology could be explained by these.
Haemachromatosis can cause raised gastrointestinal
absorption of zinc leading to accumulation, which could
potentially predispose to secondary Cu deficiency [8].
Although copper is bound to caeruloplasmin in serum,
this is not exchangeable and caeruloplasmin is not a
copper transport protein, but an oxidase. Caeruloplasmin
oxidises ferrous ions and is thus necessary for supplying
iron for haemoglobin formation. Caeruloplasmin is also
involved in iron transport in that it oxidises apotransferrin
to transferrin, and acaeruloplasminaemia causes iron
toxicity because iron builds up in tissues. It is unlikely in
our case that the hereditary haemachromatosis diagnosis
is wrong, since iron stores responded to venesection, but
low caeruloplasmin levels may have contributed to the
iron overload syndrome and also to the development of
the clinical copper deficiency syndrome.
Our hypothesis is that in this patient with relatively low
caeruloplasmin levels, the development of haemachro-
matosis led to a copper deficiency myeloneuropathy, thus
explaining all the features of this case.
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